Shanghai Science and Technology Innovation Fund

The Shanghai Science and Technology Innovation Fund (上海科创基金 / Shanghai Sci-Tech Innovation Fund) is a state-backed investment platform that appears in elsewhere's corpus primarily as a co-investor in growth-stage venture deals. In January 2026, it participated in the nearly RMB 600 million Series C round of Chengdu Zai Ling Bio, alongside Temasek's Fullerton Capital, Qiming Venture Partners, Tencent Investment, and Bluerun Ventures . The fund also backed embodied-intelligence startup Qiongche Intelligence in a multi-hundred-million-yuan Pre-A++ round in 2025, alongside Yunqi Capital, Shengyu Investment, and others . Earlier, in 2023, it was listed among the LPs in Chaoxi Capital's second RMB fund and first USD fund, alongside industrial groups and other market-oriented fund-of-funds . The corpus does not contain a detailed profile of its founding, scale, or mandate beyond these deal appearances.